Skip to main content
OpenTrials

Clinical trial condition

Hereditary Angioedema Types I and II

Explore clinical trials studying Hereditary Angioedema Types I and II. Study availability and eligibility vary by location and protocol.

13 public trials 0 recruiting studies
Refine in advanced search Browse all conditions

Hereditary Angioedema Types I and II trial results

Enrolling by Invitation

Extension Study of Oral PHA-022121 for Acute Treatment of Angioedema Attacks in Patients With Hereditary Angioedema

NCT05396105

Conditions
Angioedema, Angioedemas, Hereditary, C1 Esterase Inhibitor Deficiency, +30 more
Locations
  • Study site Birmingham, Alabama, United States
  • Study site Little Rock, Arkansas, United States
  • Study site San Diego, California, United States
  • Study site Santa Monica, California, United States
View all 60 locations
View Trial Details
Completed

Dose-ranging Study of Oral PHA-022121 for Acute Treatment of Angioedema Attacks in Patients With Hereditary Angioedema

NCT04618211

Conditions
Angioedema, Angioedemas, Hereditary, C1 Esterase Inhibitor Deficiency, +23 more
Locations
  • Study site Birmingham, Alabama, United States
  • Study site Paradise Valley, Arizona, United States
  • Study site San Diego, California, United States
  • Study site Santa Monica, California, United States
View all 36 locations
View Trial Details
Completed

Study of Oral Deucrictibant Soft Capsule for On-Demand Treatment of Angioedema Attacks in Adolescents and Adults With Hereditary Angioedema

NCT06343779

Conditions
Angioedema, Angioedemas, Hereditary, C1 Esterase Inhibitor Deficiency, +27 more
Locations
  • Study Site Birmingham, Alabama, United States
  • Study Site Paradise Valley, Arizona, United States
  • Study Site Little Rock, Arkansas, United States
  • Study Site San Diego, California, United States
View all 76 locations
View Trial Details
Completed

Dose-ranging Study of Oral PHA-022121 for Prophylaxis Against Angioedema Attacks in Patients With Hereditary Angioedema Type I or Type II

NCT05047185

Conditions
Angioedema, Angioedemas, Hereditary, C1 Esterase Inhibitor Deficiency, +23 more
Locations
  • Study site Birmingham, Alabama, United States
  • Study site Paradise Valley, Arizona, United States
  • Study site St Louis, Missouri, United States
  • Study Site Vienna, Austria
View all 19 locations
View Trial Details
Completed

Biomarker for Hereditary AngioEdema Disease

NCT03029728

Conditions
Angio Edema, Angioedema, Angioedemas, Hereditary, +22 more
Locations
  • Arabkir JMC-ICAH Yerevan, Armenia
  • Center of Allergy and Immunology Tbilisi, Georgia
  • Department of Pediatric Genetics, Amrita Institute of Medical Sciences & Research Centre Kerola, India
  • Clinica San Pablo de Surco Lima, Peru
View Trial Details
Completed

A Study to Evaluate the Clinical Pharmacology and Safety of C1-esterase Inhibitor Administered by the Subcutaneous Route

NCT01576523

Conditions
Angioedema, Angioedemas, Hereditary, Cardiovascular Diseases, +9 more
Locations
  • Study Site Atlanta, Georgia, United States
  • Study Site Chevy Chase, Maryland, United States
  • Study Site Cincinnati, Ohio, United States
  • Study Site Toledo, Ohio, United States
View Trial Details
Completed

A Study to Evaluate the Clinical Efficacy and Safety of Subcutaneously Administered C1-esterase Inhibitor in the Prevention of Hereditary Angioedema

NCT01912456

Conditions
Angioedema, Angioedemas, Hereditary, Cardiovascular Diseases, +14 more
Locations
  • Study Site Birmingham, Alabama, United States
  • Study Site Scottsdale, Arizona, United States
  • Study Site Bell Gardens, California, United States
  • Study Site La Jolla, California, United States
View all 39 locations
View Trial Details
Completed

A Study to Evaluate the Long-term Clinical Safety and Efficacy of Subcutaneously Administered C1-esterase Inhibitor in the Prevention of Hereditary Angioedema

NCT02316353

Conditions
Angioedema, Angioedemas, Hereditary, Cardiovascular Diseases, +9 more
Locations
  • Study Site Birmingham, Alabama, United States
  • Study Site Scottsdale, Arizona, United States
  • Study Site La Jolla, California, United States
  • Study Site Orange, California, United States
View all 32 locations
View Trial Details
Completed

Postmarketing Immunogenicity Study in HAE Subjects Treated With Berinert

NCT01467947

Conditions
Angioedema, Angioedemas, Hereditary, Cardiovascular Diseases, +9 more
Locations
  • MHAT "Tsaritsa Yoanna" Sofia, Bulgaria
  • Semmelweis University Budapest, Hungary
  • Jagiellonian University Krakow, Poland
  • Spitalul Clinic Judeţean Mureş,Secţia Clinică Medicină Internă,Compartimentul Alergologie şi Imunologie Târgu-Mures, Mureș County, Romania
View Trial Details

Related conditions